About (BLCO) Bausch + Lomb Corporation

Company Background

Bausch + Lomb Corporation, symbol BLCO on the Toronto Stock Exchange (TSX) and New York Stock Exchange (NYSE), is a global eye health company dedicated to protecting, enhancing, and restoring vision for millions of people worldwide. Founded in 1853 and headquartered in Vaughan, Ontario, Bausch + Lomb is one of the most recognized and trusted brands in the ophthalmic industry. The company operates across three primary business segments—Vision Care, Ophthalmic Pharmaceuticals, and Surgical—offering a comprehensive portfolio that includes contact lenses, lens care products, prescription eye medications, and surgical equipment. With over 170 years of innovation, Bausch + Lomb continues to advance eye health through research, technology, and a deep commitment to improving quality of life.

Market Position

Bausch + Lomb holds a leading position in the global eye care industry, serving customers in more than 100 countries. The company’s Vision Care segment is a market leader in contact lenses and related products, featuring popular brands such as Biotrue, ULTRA, and INFUSE. Its Pharmaceutical division provides a diverse range of prescription treatments for ocular conditions like glaucoma, dry eye, and retinal diseases. The Surgical segment supports ophthalmic surgeons with state-of-the-art technologies for cataract and vitreoretinal procedures. Backed by a strong global distribution network and an extensive product pipeline, Bausch + Lomb maintains a competitive edge through innovation, brand strength, and clinical expertise. Its deep heritage and focus on patient outcomes make it a preferred partner among eye care professionals worldwide.

Key Financial and Industry Highlights

Bausch + Lomb demonstrates consistent financial performance, supported by steady demand for vision correction and eye health solutions. The company benefits from strong recurring revenue streams driven by its diversified product base and global reach. Continued investment in research and development fuels innovation in next-generation contact lenses, surgical devices, and pharmaceuticals. The company’s strategic initiatives—such as expanding its presence in emerging markets and enhancing digital engagement with consumers and practitioners—position it for long-term growth in the rapidly evolving eye care sector.

As aging populations and digital lifestyles increase global demand for vision care, Bausch + Lomb remains at the forefront of addressing these needs through advanced technologies and sustainable business practices. With a legacy of trust, scientific excellence, and patient-centered innovation, Bausch + Lomb Corporation continues to lead the way in global eye health and vision enhancement.